P98170 (XIAP_HUMAN) Homo sapiens (Human)

E3 ubiquitin-protein ligase XIAP UniProtKBInterProSTRINGInteractive Modelling

497 aa; Sequence (Fasta)

Available Structures

72 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP
1g3f
 Heteromer
Q9NR28; 		241-356
1×ZN;
Assess
CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
1i3o
 Heteromer
P42574; 		127-237
2×ZN;
Assess
STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP-BIR3
1nw9
 Heteromer
P55211; 		256-346
1×ZN;
Assess
CRYSTAL STRUCTURE OF SMAC BOUND TO XIAP-BIR3 DOMAIN
1g73
 Heteromer
Q9NR28; 		256-344
Assess
The Crystal Structure of TAB1 and BIR1 complex
2pop
 Heteromer
Q15750; 		19-100
2×ZN;
Assess
Structure of RIP2K dimer bound to the XIAP BIR2 domain
8aza
 Heteromer
O43353; 		159-234
1×ZN;
Assess
BIRC4 RING in complex with dimeric ubiquitin variant
5o6t
 Heteromer
P0CG47; 		434-497
4×ZN; 2×EDO;
Assess
CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP
1i51
 Heteromer
P55210; 		135-152
Assess
CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX
1i4o
 Heteromer
P55210; 		134-150
Assess
Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex
1kmc
 Heteromer
P55210; 		134-150
Assess
AVPF bound to BIR3-XIAP
2opz
homo-2-mer249-357
2×ZN;
Assess
XIAP-BIR3 in complex with a potent divalent Smac mimetic
4ec4
homo-2-mer246-354
2×ZN; 1×0O6; 1×P33;
Assess
Fragment Derived XIAP inhibitor
6h6q
homo-2-mer248-354
2×ZN; 2×FUK;
Assess
XIAP in complex with small molecule
5oqw
homo-2-mer249-354
2×ZN; 1×NA; 2×A4E;
Assess
Smac mimic bound to BIR3-XIAP
2opy
homo-2-mer249-354
2×ZN; 2×CO9;
Assess
Crystal Structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac010
3cm2
homo-2-mer253-355
2×ZN; 2×X23;
Assess
Crystal Structure of XIAP-BIR3 domain in complex with Smac-mimetic compuond, Smac005
3cm7
homo-2-mer254-355
2×ZN; 4×X22;
Assess
Crystal structure of XIAP BIR3 domain in complex with a Smac-mimetic compound
3eyl
homo-2-mer254-354
2×ZN; 2×SMK;
Assess
Crystal structure of XIAP BIR3 with T3256336
4hy0
homo-2-mer254-349
4×ZN; 2×1AQ;
Assess
Crystal structure of XIAP-BIR2 domain
4j3y
homo-2-mer152-234
2×ZN;
Assess
Crystal structure of XIAP BIR1 domain (P21 form)
2qra
homo-2-mer20-99
2×ZN; 4×EOH;
Assess
Crystal structure of XIAP BIR1 domain (I222 form)
2poi
homo-2-mer22-99
2×ZN;
Assess
Structure of XIAP-BIR1 domain in complex with an NF023 analog
6gjw
homo-2-mer21-98
2×ZN; 1×F2H;
Assess
Structure of XIAP-BIR1 in complex with NF023
4mtz
homo-2-mer21-98
2×ZN; 1×0BU;
Assess
Crystal structure of the RING domain of human XIAP
8w5a
homo-2-mer434-497
4×ZN; 1×CA;
Assess
Crystal structure of the F495L mutant XIAP RING domain
4ic3
homo-2-mer434-497
4×ZN; 2×NI;
Assess
Crystal structure of the XIAP RING domain
4ic2
homo-2-mer434-497
4×ZN; 1×NI;
Assess
Crystal structure of the RING domain of human XIAP treated with arsenic trioxide
8w59
homo-2-mer434-495
4×ZN; 1×CA;
Assess
AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-2 DOMAIN OF XIAP
1c9q
monomer124-240
1×ZN;
Assess
NMR Structure of an Antagonists of the XIAP-Caspase-9 Interaction Complexed to the BIR3 domain of X…
1tft
monomer241-356
1×ZN; 1×997;
Assess
NMR Structure of an Antagonists of the XIAP-Caspase-9 Interaction Complexed to the BIR3 domain of X…
1tfq
monomer241-356
1×ZN; 1×998;
Assess
AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-3 DOMAIN OF XIAP
1f9x
monomer241-356
1×ZN;
Assess
Fragment Derived XIAP inhibitor
6h6r
monomer248-354
1×ZN; 1×NA; 1×FUE;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 4
5c3k
monomer249-354
1×ZN; 1×4XF;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 17
5c7d
monomer249-354
1×ZN; 1×4YF;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 18
5c7c
monomer249-354
1×ZN; 1×4YC;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 21
5c83
monomer249-354
1×ZN; 1×4YN;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 20
5c84
monomer249-354
1×ZN; 1×4YL;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 7
5c7a
monomer249-354
1×ZN; 1×4YE;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2
5c0l
monomer249-354
1×ZN; 1×4WJ;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 1
5c3h
monomer249-354
1×ZN; 1×4XE;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 5
5c7b
monomer249-354
1×ZN; 1×4YD;
Assess
Small Molecule inhibitors of IAP
5m6e
monomer249-353
1×ZN; 1×NA; 1×DMS; 1×7HT;
Assess
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 3
5c0k
monomer249-352
1×ZN; 2×EDO; 1×4WK;
Assess
Small Molecule inhibitors of IAP
5m6f
monomer249-352
1×ZN; 1×NA; 1×7HU;
Assess
Small Molecule inhibitors of IAP
5m6l
monomer249-352
1×ZN; 1×NA; 1×7H9;
Assess
Small Molecule inhibitors of IAP
5m6m
monomer249-351
1×ZN; 1×NA; 1×7H8;
Assess
Small Molecule inhibitors of IAP
5m6h
monomer249-351
1×ZN; 1×NA; 1×7J6;
Assess
Crystal structure of XIAP-BIR3 in complex with a cIAP1-selective SM
6ey2
monomer254-352
1×ZN; 1×C3T;
Assess
Crystal structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac005
3clx
monomer256-354
1×ZN; 1×X22;
Assess
XIAP BIR3 bound to a Smac Mimetic
2jk7
monomer250-346
1×BI6; 1×ZN;
Assess
Crystal structure of XIAP-BIR3 in complex with a bivalent compound
3g76
monomer252-348
1×ZN; 1×CZ3;
Assess
Crystal Structure of XIAP BIR3 with a Bivalent Smac Mimetic
2vsl
monomer250-345
1×15P; 1×ZN;
Assess
142D6 bound to BIR3-XIAP
8gh7
monomer253-345
1×ZN; 1×7PE;
Assess
Structure of XIAP-BIR3 and inhibitor
4kmp
monomer256-348
1×ZN;
Assess
Solution structure of UBA domain of XIAP
2kna
monomer357-449
Assess
Crystal structure of XIAP BIR3 with CS3
3hl5
monomer256-346
1×ZN; 1×9JZ;
Assess
Crystal structure of cIAP1 BIR3 bound to GDC0152
3uw4
monomer262-346
2×ZN;
Assess
Crystal structure of XIAP-BIR2 domain with AMRV bound
4j48
monomer152-234
1×ZN; 1×SO4;
Assess
Crystal structure of XIAP-BIR2 domain with AIAV bound
4j44
monomer152-233
1×ZN;
Assess
Crystal structure of XIAP-BIR2 domain with SVPI bound
4j47
monomer152-233
1×ZN;
Assess
Crystal structure of XIAP-BIR2 domain with AVPI bound
4j46
monomer152-233
1×ZN;
Assess
Crystal structure of XIAP-BIR2 domain with ATAA bound
4j45
monomer152-233
1×ZN;
Assess
Crystal structure of XIAP-Bir2 with a bound spirocyclic benzoxazepinone inhibitor.
4kjv
monomer152-233
1×ZN; 1×1RK;
Assess
Crystal structure of XIAP-Bir2 with a bound benzodiazepinone inhibitor.
4kju
monomer152-232
1×ZN; 1×1RH;
Assess
Structure of XIAP-BIR1 V86E mutant
6qci
monomer21-98
1×ZN; 1×NA;
Assess
Crystal structure of XIAP BIR1 domain
4oxc
monomer22-99
1×ZN;
Assess
Crystal structure of XIAP-BIR2 domain complexed with ligand bound
4wvt
monomer156-231
1×ZN;
Assess
CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND
4wvu
monomer156-231
1×ZN; 1×SO4; 1×GOL;
Assess
Crystal structure of XIAP-BIR2 domain complexed with (S)-3-(4-methoxyphenyl)-2-((S)-2-((S)-1-((S)-2…
4wvs
monomer156-231
1×ZN; 3×SO4; 1×GOL;
Assess
Solution structure of the ring domain of the Baculoviral IAP repeat-containing protein 4 from Homo …
2ecg
monomer430-497
2×ZN;
Assess
Crystal structure of the BIR domain of MLIAP bound to GDC0152
3uw5
monomer326-343
1×ZN; 1×SO4;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2kna.1.Amonomer0.74367-448
100.00
Assess
3t6p.1.Amonomer0.71261-417
1×ZN;42.04
Assess
8w5a.1.Bmonomer0.64434-497
2×ZN;100.00
Assess